Viking Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
1.47 |
6.21 |
4.53 |
158.62 |
586.35 |
| Przychód Δ r/r |
0.00% |
inf% |
322.42% |
-27.00% |
3397.79% |
269.67% |
| Przychód (min) |
0.00 |
1.47 |
6.21 |
4.53 |
158.62 |
586.35 |
| Przychód (max) |
0.00 |
1.47 |
6.21 |
4.53 |
158.62 |
586.35 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-113.12 |
-262.36 |
-353.56 |
-427.79 |
-348.37 |
-158.42 |
| Zysk netto % |
-inf% |
-17840.22% |
-5691.54% |
-9433.68% |
-219.63% |
-27.02% |
| EPS (średnia) |
-0.96 |
-2.41 |
-3.01 |
-3.47 |
-3.19 |
-1.45 |
| Liczba analityków (Przychody) |
0 |
11 |
11 |
14 |
6 |
9 |
| Liczba analityków (EPS) |
12 |
11 |
13 |
12 |
7 |
10 |
| symbol |
VKTX |
VKTX |
VKTX |
VKTX |
VKTX |
VKTX |